Completed
Entia Liberty: Home Study - Evaluation of Patient Preference for a Novel Full Blood Count Home Testing Device Versus Routine Venous Monitoring
What is being collected
Data Collection
Collected at a single point in time - Cross-sectionalWho is being recruted
Neoplasms
Over 18 Years
+11 Eligibility Criteria
How is the trial designed
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Observational
Study Start: January 2023
Summary
Principal SponsorEntia Ltd
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: January 6, 2023
Actual date on which the first participant was enrolled.Participants will be testing with the home monitoring device over the course of their treatment. They are to self-test on days where they are due to be going into hospital for their routine pre-treatment blood tests. Participants will be asked to fill in interim questionnaires and a final questionnaire to answer the study objectives.
Official TitleEntia Liberty: Home Study - Evaluation of Patient Preference for a Novel Full Blood Count Home Testing Device Versus Routine Venous Monitoring
Principal SponsorEntia Ltd
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
22 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Neoplasms
Criteria
9 inclusion criteria required to participate
Age ≥ 18
Adequate English language skills (not requiring a translator) to participate in participant training and use the Liberty device
Patients willing and able to perform capillary blood self-testing at the same frequency as routine full blood count monitoring
Patients capable of providing informed consent before attending training
Show More Criteria
2 exclusion criteria prevent from participating
Patients with haematological malignancies
Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Liberty device or participation in training unless they have a nominated caregiver who is capable of assisting with each test
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
The Christie NHS Foundation Trust
Manchester, United KingdomOpen The Christie NHS Foundation Trust in Google MapsCompletedOne Study Center